Home
>
National Drug Code (NDC)
>
Taxotere
Taxotere - 0075-8001-20 - (docetaxel)
Drug Information of Taxotere
| Product NDC: | 0075-8001 |
| Proprietary Name: | Taxotere |
| Non Proprietary Name: | docetaxel |
| Active Ingredient(s): | 40 mg/mL & nbsp; docetaxel |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Taxotere
| Product NDC: | 0075-8001 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020449 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100515 |
Package Information of Taxotere
| Package NDC: | 0075-8001-20 |
| Package Description: | .5 mL in 1 VIAL, GLASS (0075-8001-20) |
NDC Information of Taxotere
| NDC Code | 0075-8001-20 |
| Proprietary Name | Taxotere |
| Package Description | .5 mL in 1 VIAL, GLASS (0075-8001-20) |
| Product NDC | 0075-8001 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | docetaxel |
| Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100515 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | DOCETAXEL |
| Strength Number | 40 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
